21/10/2020 (Agence Europe) – The agreement between the European Union and Johnson & Johnson to supply a total of up to 400 million doses of a future vaccine is now official. The European Commission announced on Wednesday 21 October that it had signed the advance purchase agreement it concluded on 8 October, and which is now effective (see EUROPE B12577A3). (SPj)